Why Curaleaf Is the Best Marijuana Stock You’ll Find TodayPosted by On

The coronavirus pandemic brought chaos to most other industries, but did the opposite for the marijuana industry. Cannabis sales skyrocketed in the pandemic after the drug was deemed an “essential” product during lockdown. Sales are still on the rise this year. The U.S. cannabis companies, in particular, did exceptionally well in 2020.

Among them, Massachusetts-based Curaleaf Holdings (OTC:CURLF) is one of my favorites. Curaleaf stands in a much better position than many of its Canadian counterparts, with its recent threefold revenue growth bringing it closer to profitability. Its market cap of $9.1 billion is getting close to that of Canopy Growth (market cap of $10.7 billion), one of the most popular Canadian cannabis players. But Canopy is still struggling to achieve positive earnings before interest, taxation, depreciation, and amortization (EBITDA). 

Man inspecting cannabis plants in field

Image source: Getty Images.

Even with a limited legal market in the U.S., Curaleaf has done wonders and is carving its path toward success with smart growth strategies. As more and more states legalize marijuana, let’s take a look at how Curaleaf is positioned to take advantage of that and why it could be a good fit for your portfolio.

Its rising revenues are bringing it closer to profitability 

Positive EBITDA, a rare occurrence for cannabis companies, reveals how well a company is handling its operating expenses. Meanwhile, net income — or true profitability –…

Original Author Link click here to read complete story..

The coronavirus pandemic brought chaos to most other industries, but did the opposite for the marijuana industry. Cannabis sales skyrocketed in the pandemic after the drug was deemed an “essential” product during lockdown. Sales are still on the rise this year. The U.S. cannabis companies, in particular, did exceptionally well in 2020.

Among them, Massachusetts-based Curaleaf Holdings (OTC:CURLF) is one of my favorites. Curaleaf stands in a much better position than many of its Canadian counterparts, with its recent threefold revenue growth bringing it closer to profitability. Its market cap of $9.1 billion is getting close to that of Canopy Growth (market cap of $10.7 billion), one of the most popular Canadian cannabis players. But Canopy is still struggling to achieve positive earnings before interest, taxation, depreciation, and amortization (EBITDA). 

Man inspecting cannabis plants in field

Image source: Getty Images.

Even with a limited legal market in the U.S., Curaleaf has done wonders and is carving its path toward success with smart growth strategies. As more and more states legalize marijuana, let’s take a look at how Curaleaf is positioned to take advantage of that and why it could be a good fit for your portfolio.

Its rising revenues are bringing it closer to profitability 

Positive EBITDA, a rare occurrence for cannabis companies, reveals how well a company is handling its operating expenses. Meanwhile, net income — or true profitability –…



Source link

News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.